Ticker: APLS

Company: Apellis Pharmaceuticals, Inc.

Person: DeLong Mark Jeffrey, officer

Transaction date: Jan. 22, 2026

Reporting date: Jan. 23, 2026

Average share price: 21.765400000000003

Sold 3371.0 shares for 73371.16